Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients

Bisphosphonates are well known inhibitors of osteoclast activity and thus may be employed to influence osteoblast activity. The present study was designed to evaluate the in vivo effects of zoledronic acid (ZA) on the proliferation and osteoblastic commitment of mesenchymal stem cells (MSC) in osteo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Luca Dalle Carbonare, Monica Mottes, Giovanni Malerba, Antonio Mori, Martina Zaninotto, Mario Plebani, Alessandra Dellantonio, Maria Teresa Valenti
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2017-06-01
Serie:International Journal of Molecular Sciences
Ämnen:
mesenchymal stem cells
Runt-related transcription factor 2 (RUNX2)
zoledronic acid
gene expression
bone turnover
differentiation
Länkar:http://www.mdpi.com/1422-0067/18/6/1261
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk